和仁科技(300550.SZ):預中標1.66億元西安市紅會醫院多院區一體化‘智慧醫院’場景應用項目
格隆匯11月23日丨和仁科技(300550.SZ)公佈,公司獲悉陝西採購與招標網於2022年11月22日公吿了“西安市紅會醫院多院區一體化‘智慧醫院’場景應用項目國內招標中標候選人公示”,公示內容顯示,經評標委員會評審,和仁科技為中標候選人第一名,公示期三天。項目服務期為合同簽訂後一年內。根據預中標報價測算,預計公司此次西安市紅會醫院項目中標金額為1.66億元,約佔公司2021年度主營業務收入的35.73%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.